Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
The feature you requested does not exist. However, we suggest the following feature:

Johnson & Johnson : Post-effective amendment to an S-8 filing

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/25/2019 | 05:16pm EDT

As filed with the Securities and Exchange Commission on June 25, 2019

Registration No. 333-211250

Registration No. 333-188368

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

________________

POST-EFFECTIVE AMENDMENT NO.1

FILE NO. 333-211250

POST-EFFECTIVE AMENDMENT NO.1

FILE NO. 333-188368

to

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

Johnson & Johnson

(Exact Name of Registrant as Specified in its Charter)

New Jersey

22-1024240

(State or Other Jurisdiction of

(I.R.S. Employer Identification

Incorporation or Organization)

Number)

One Johnson & Johnson Plaza

New Brunswick, New Jersey 08933

(Address of Principal Executive Offices) (Zip Code)

(732) 524-0400

(Registrant's Telephone Number, Including Area Code)

Johnson & Johnson Savings Plan

Johnson & Johnson Retirement Savings Plan

Johnson & Johnson Savings Plan for Union Represented Employees

(Full Title of the Plan)

Matthew Orlando

Johnson & Johnson

Corporate Secretary

One Johnson & Johnson Plaza

New Brunswick, New Jersey 08933 (Name and Address of Agent for Service)

(732) 524-0400

(Telephone Number, Including Area Code, of Agent for Service)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer x

Accelerated filer

Non-acceleratedfiler (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.

EXPLANATORY NOTE

Registration Statement on Form S-8 (File No. 333-211250), initially filed on May 10, 2016 by Johnson & Johnson (the "Registrant"), and Registration Statement on Form S-8 (File No. 333-188368), initially filed on May 3, 2013 by the Registrant (together, the "Registration Statements"), registered 40 million shares and 20 million shares, respectively, of common stock of the Registrant ("Common Stock"), and the plan interests associated therewith, pursuant to the Johnson & Johnson Savings Plan (the "Savings Plan"), the Johnson & Johnson Retirement Savings Plan (the "Retirement Savings Plan") and the Johnson & Johnson Savings Plan for Union Represented Employees (the "Union Plan").

The Union Plan merged with and into the Savings Plan on January 5, 2018 (the "plan merger date"). This Post-Effective Amendment No. 1 to the Registration Statements is filed to deregister the plan interests with respect to the Union Plan. All shares of Common Stock that remain unsold under the Registration Statements as of the plan merger date shall remain available for issuance under the Savings Plan and the Retirement Savings Plan.

SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New Brunswick, State of New Jersey, on this 25th day of June, 2019.

JOHNSON & JOHNSON

By: /s/Matthew Orlando

Matthew Orlando

Corporate Secretary

No other person is required to sign this Post-Effective Amendment No. 1 to the Registration Statements in reliance on Rule 478 of the Securities Act.

Pursuant to the requirements of the Securities Act, the administrator of the Johnson & Johnson Retirement Savings Plan has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New Brunswick, State of New Jersey, on this 25th day of June, 2019.

JOHNSON & JOHNSON RETIREMENT SAVINGS PLAN

By: /s/ Warren Luther

Warren Luther

Member, Pension and Benefits Committee

Pursuant to the requirements of the Securities Act, the administrator of the Johnson & Johnson Savings Plan, as successor in interest to the Johnson & Johnson Savings Plan for Union Represented Employees, has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New Brunswick, State of New Jersey, on this 25th day of June, 2019.

JOHNSON & JOHNSON SAVINGS PLAN FOR UNION

REPRESENTED EMPLOYEES (BY THE JOHNSON &

JOHNSON SAVINGS PLAN, AS SUCCESSOR IN INTEREST

TO THE UNION PLAN)

By: /s/ Warren Luther

Warren Luther

Member, Pension and Benefits Committee

Pursuant to the requirements of the Securities Act, the administrator of the Johnson & Johnson Savings Plan has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New Brunswick, State of New Jersey, on this 25th day of June, 2019.

JOHNSON & JOHNSON SAVINGS PLAN

By: /s/ Warren Luther

Warren Luther

Member, Pension and Benefits Committee

Disclaimer

Johnson & Johnson published this content on 25 June 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 June 2019 21:15:09 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
06/25JOHNSON & JOHNSON : Post-effective amendment to an S-8 filing
PU
06/25JOHNSON & JOHNSON : Certification of Termination of Registration
PU
06/25SPECIAL REPORT : How judges added to the grim toll of opioids
RE
06/24JOHNSON & JOHNSON : Oklahoma judge approves Teva's $85 million opioid settlement
RE
06/24JOHNSON & JOHNSON : VA declines broad coverage for new J&J depression drug toute..
AQ
06/20JOHNSON & JOHNSON : 4 Ways Johnson & Johnson Is Helping Heroes Who Work at the V..
PU
06/20JOHNSON & JOHNSON : Janssen Pharmaceuticals, Inc - An Important Message about SP..
AQ
06/19JOHNSON & JOHNSON : Oklahoma medical examiner testifies in state opioid lawsuit
AQ
06/19JOHNSON & JOHNSON : Perch teams with Vodafone on retail digital experiences
AQ
06/19JOHNSON & JOHNSON : UM Studios Wins First-Ever Cannes Lions Grand Prix for Docum..
AQ
More news
Financials ($)
Sales 2019 81 223 M
EBIT 2019 25 632 M
Net income 2019 19 737 M
Debt 2019 8 612 M
Yield 2019 2,62%
P/E ratio 2019 20,12
P/E ratio 2020 18,29
EV / Sales 2019 4,78x
EV / Sales 2020 4,39x
Capitalization 380 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 149 $
Spread / Average Target 4,0%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Charles O. Prince Independent Director
William David Perez Independent Director
Anne M. Mulcahy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON11.77%348 981
PFIZER0.05%233 072
ROCHE HOLDING LTD.13.50%227 848
NOVARTIS21.44%220 893
MERCK AND COMPANY11.91%206 641
ELI LILLY AND COMPANY-0.20%113 364